Loading...
Market
Which company will see the highest stock price increase by the end of 2024 due to the FDA approval of Illumina's assay?
3
Resolution / Starting Odds
Illumina • 25%
Bayer • 25%
Lilly • 25%
Other • 25%
Stock market data from financial reports
Story
FDA Approves Illumina's TruSight Oncology Comprehensive for Bayer and Lilly Therapies
Aug 27, 2024, 02:01 PM
The U.S. Food and Drug Administration (FDA) has approved Illumina's TruSight Oncology Comprehensive assay, a cancer biomarker test designed to rapidly match patients to targeted therapies. This test includes two companion diagnostics and is specifically approved as a companion diagnostic (CDx) for kinase inhibitors from pharmaceutical companies Bayer and Lilly. The assay identifies patients with NTRK gene fusions who may benefit from Bayer's Vitrakvi (larotrectinib) and those with RET fusion-positive cancers who may benefit from Lilly's Retevmo (selpercatinib).
View original story
Similar markets
A cancer diagnostics company • 25%
A gene sequencing company • 25%
A biotech company unrelated to cancer diagnostics • 25%
No major acquisition • 25%
Apple • 25%
Google • 25%
Microsoft • 25%
Amazon • 25%
American Battery Technology Co. • 25%
Albemarle • 25%
Forge Battery • 25%
Group14 Technologies • 25%
NVIDIA • 25%
ASML • 25%
Applied Materials • 25%
Lam Research • 25%
FuboTV • 25%
Disney • 25%
Fox • 25%
Warner Bros. Discovery • 25%
Nvidia • 25%
Apple • 25%
Microsoft • 25%
Amazon • 25%
BlackRock • 25%
Microsoft • 25%
Nvidia • 25%
Global Infrastructure Partners • 25%
Robinhood • 25%
Interactive Brokers • 25%
Kalshi • 25%
Polymarket • 25%
AMC • 25%
Cinemark • 25%
IMAX • 25%
Disney • 25%
Google (Alphabet) • 25%
OpenAI (via Microsoft) • 25%
Midjourney • 25%
Stability AI • 25%
Salesforce's stock price increases the most • 25%
Workday's stock price increases the most • 25%
Klarna's stock price increases the most • 25%
No significant change in stock prices • 25%
Illumina • 25%
Thermo Fisher Scientific • 25%
Bio-Rad Laboratories • 25%
Other • 25%